Status:
WITHDRAWN
Effects of Insulin on Hypotension and Sarcopenia
Lead Sponsor:
Kenneth Madden
Conditions:
Diabetes
Sarcopenia
Eligibility:
All Genders
65+ years
Brief Summary
In this study investigator's aim to determine the impact of insulin therapy on hypotension and sarcopenia
Detailed Description
Diabetes is common in the elderly. By the age of 70, approximately 25% of the population has diabetes and another 25% is at risk for diabetes. Elderly patients with diabetes are at increased risk for ...
Eligibility Criteria
Inclusion
- 65 years of age or older
- Type 2 diabetes for at least 5 years
- Insulin naive
- now needs insulin to manage diabetes
Exclusion
- anemia as defined by serum hematocrit
- abnormal liver function tests
- elevated serum creatinine
- smoked within last 5 years
- musculoskeletal or neurological condition that would preclude tilt table testing or orthostatic vitals
- aortic stenosis
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03248271
Start Date
October 1 2017
End Date
January 10 2023
Last Update
January 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia - Gerontology Research Lab
Vancouver, British Columbia, Canada, V5Z 1M9